Thought leadership from the Day One team
Jeremy Bender on Biotech2050
Day One’s CEO discusses transforming pediatric cancer care & leading biotech with purpose
Giving New Life to Medicines – and New Options to Patients Fighting Cancer
Davy Chiodin, CDO, reflects on Day One’s start and how one treatment’s long journey to patients has put the company in the position to hopefully help more people with cancer.
Day One’s Next Chapter in Oncology Innovation
Dr. Jeremy Bender, CEO, highlights Day One’s progress and exciting opportunities that lie ahead.
Pediatric Oncology’s Changing Regulatory Landscape and How to Navigate It
The Conference Forum, IO360 – Elly Barry, M.D., CMO, discusses regulatory changes in pediatric oncology, differences in adult and pediatric clinical trials & benefits of early engagement with the academic community.
Building Pediatric Oncology from the Ground Up
BioCentury Show – Jeremy Bender, CEO, discusses the rise of Day One, our approach to drug development and strategy for long-term sustainability.
Navigating the Pediatric Drug Development Realm
The ALADDIN Podcast – Davy Chiodin, CDO, discusses different and innovative approaches to pediatric drug development including a multi-stakeholder collaboration.